Junlian Gu

2.4k total citations
57 papers, 1.9k citations indexed

About

Junlian Gu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Junlian Gu has authored 57 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 13 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Junlian Gu's work include Fibroblast Growth Factor Research (9 papers), Genomics, phytochemicals, and oxidative stress (8 papers) and Kruppel-like factors research (7 papers). Junlian Gu is often cited by papers focused on Fibroblast Growth Factor Research (9 papers), Genomics, phytochemicals, and oxidative stress (8 papers) and Kruppel-like factors research (7 papers). Junlian Gu collaborates with scholars based in China, United States and Mongolia. Junlian Gu's co-authors include Lu Cai, Shudong Wang, Yi Tan, Yufeng Tang, Yonggang Wang, Yuanfang Guo, Zhiguo Zhang, Mengjie Xiao, Shanshan Zhou and Chi Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Diabetes and Scientific Reports.

In The Last Decade

Junlian Gu

54 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junlian Gu China 26 1.2k 427 265 207 206 57 1.9k
Qi‐Zhu Tang China 24 936 0.8× 740 1.7× 276 1.0× 290 1.4× 204 1.0× 47 1.9k
Hongmei Ren China 24 1.3k 1.1× 245 0.6× 270 1.0× 140 0.7× 121 0.6× 73 1.9k
Bo Ding China 27 1.5k 1.3× 618 1.4× 372 1.4× 260 1.3× 167 0.8× 110 2.5k
Iván P. Uray United States 20 1.3k 1.1× 475 1.1× 267 1.0× 434 2.1× 152 0.7× 40 2.3k
Si‐Chi Xu China 20 930 0.8× 874 2.0× 285 1.1× 260 1.3× 247 1.2× 28 1.9k
Yuan Qin China 24 1.1k 1.0× 192 0.4× 459 1.7× 148 0.7× 282 1.4× 119 2.1k
Joseph W. Gordon Canada 23 1.1k 0.9× 322 0.8× 297 1.1× 125 0.6× 378 1.8× 52 1.8k
Can Hu China 18 814 0.7× 603 1.4× 298 1.1× 204 1.0× 221 1.1× 31 1.6k
Bong Sook Jhun United States 25 1.5k 1.3× 225 0.5× 204 0.8× 134 0.6× 246 1.2× 51 2.2k

Countries citing papers authored by Junlian Gu

Since Specialization
Citations

This map shows the geographic impact of Junlian Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junlian Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junlian Gu more than expected).

Fields of papers citing papers by Junlian Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junlian Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junlian Gu. The network helps show where Junlian Gu may publish in the future.

Co-authorship network of co-authors of Junlian Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Junlian Gu. A scholar is included among the top collaborators of Junlian Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junlian Gu. Junlian Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Yuanfang, Jie Wang, Dongmei Zhang, et al.. (2025). Diabetes-associated sleep fragmentation impairs liver and heart function via SIRT1-dependent epigenetic modulation of NADPH oxidase 4. Acta Pharmaceutica Sinica B. 15(3). 1480–1496. 1 indexed citations
2.
Zhang, Xiaohui, Xinyu Tang, Ting Gao, et al.. (2025). Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1. Acta Pharmaceutica Sinica B. 15(7). 3591–3610.
3.
Ma, Bin, Hui Wei, Danyang Li, et al.. (2025). Lipid metabolism-related genes are involved in the formation of macrophage extracellular traps in allergic airway inflammation. Genes and Immunity. 26(2). 96–110.
4.
Guo, Yuanfang, Yufeng Tang, Guangping Lu, & Junlian Gu. (2023). p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act. Nutrients. 15(10). 2259–2259. 15 indexed citations
5.
Wang, Kunli, Linghua Kong, Xin Wen, et al.. (2023). The Positive Effect of 6-Gingerol on High-Fat Diet and Streptozotocin-Induced Prediabetic Mice: Potential Pathways and Underlying Mechanisms. Nutrients. 15(4). 824–824. 10 indexed citations
6.
Lu, Guangping, Jiahao Li, Ting Gao, et al.. (2023). Integration of dietary nutrition and TRIB3 action into diabetes mellitus. Nutrition Reviews. 82(3). 361–373. 5 indexed citations
7.
Cui, Weiwei, Huimin Cheng, Ruihao Zhang, et al.. (2023). Cholesterol mediated ferroptosis suppression reveals essential roles of Coenzyme Q and squalene. Communications Biology. 6(1). 1108–1108. 42 indexed citations
8.
Gao, Ting, Jie Wang, Mengjie Xiao, et al.. (2023). SESN2-Mediated AKT/GSK-3β/NRF2 Activation to Ameliorate Adriamycin Cardiotoxicity in High-Fat Diet–Induced Obese Mice. Antioxidants and Redox Signaling. 40(10-12). 598–615. 5 indexed citations
9.
10.
Liu, Qingbo, Jiahao Li, Mengjie Xiao, et al.. (2022). Co-Treatment With Resveratrol and FGF1 Protects Against Acute Liver Toxicity After Doxorubicin Treatment via the AMPK/NRF2 Pathway. Frontiers in Pharmacology. 13. 940406–940406. 17 indexed citations
11.
Wang, Jie, Mengjie Xiao, Jie Wang, et al.. (2021). NRF2-Related Epigenetic Modifications in Cardiac and Vascular Complications of Diabetes Mellitus. Frontiers in Endocrinology. 12. 598005–598005. 13 indexed citations
12.
Zhang, Jingjing, Mengjie Xiao, Shudong Wang, et al.. (2021). Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways. Cellular and Molecular Life Sciences. 78(7). 3105–3125. 63 indexed citations
13.
Xiao, Mengjie, Yufeng Tang, Shudong Wang, et al.. (2021). The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms. Frontiers in Endocrinology. 12. 598008–598008. 8 indexed citations
14.
Gu, Junlian, Ying Lei, Dezhong Wang, et al.. (2020). Curtailing FGF19’s mitogenicity by suppressing its receptor dimerization ability. Proceedings of the National Academy of Sciences. 117(46). 29025–29034. 18 indexed citations
15.
Gu, Junlian, Yang Li, Jun Zeng, et al.. (2017). Knockdown of HIF-1α by siRNA-expressing plasmid delivered by attenuated Salmonella enhances the antitumor effects of cisplatin on prostate cancer. Scientific Reports. 7(1). 7546–7546. 38 indexed citations
16.
Huang, Zhifeng, Yi Tan, Junlian Gu, et al.. (2017). Uncoupling the Mitogenic and Metabolic Functions of FGF1 by Tuning FGF1-FGF Receptor Dimer Stability. Cell Reports. 20(7). 1717–1728. 71 indexed citations
17.
Zhang, Chi, Zhifeng Huang, Junlian Gu, et al.. (2015). Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway. Diabetologia. 58(8). 1937–1948. 99 indexed citations
18.
Zhong, Lingzhi, Yang Wang, Wenxue Li, et al.. (2014). Heme oxygenase-1 silencing increases the sensitivity of human osteosarcoma MG63 cells to arsenic trioxide. Molecular and Cellular Biochemistry. 392(1-2). 135–144. 8 indexed citations
19.
Zhang, Zhiguo, Shudong Wang, Shanshan Zhou, et al.. (2014). Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway. Journal of Molecular and Cellular Cardiology. 77. 42–52. 164 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qi‐Zhu Tang Breakdown of academic impact, for papers by Hongmei Ren Breakdown of academic impact, for papers by Bo Ding Breakdown of academic impact, for papers by Iván P. Uray Breakdown of academic impact, for papers by Si‐Chi Xu Breakdown of academic impact, for papers by Yuan Qin Breakdown of academic impact, for papers by Joseph W. Gordon Breakdown of academic impact, for papers by Can Hu Breakdown of academic impact, for papers by Bong Sook Jhun
Rankless by CCL
2026